GLP-1 drugs are reshaping consumer priorities, with appetite suppression driving demand for high-quality protein.
App to visualize future risks and support behavioral change for elderly self-care
The solution is specifically authorized for the nutritional management of very low birth weight infants and those with congenital conditions.
EFSA’s advice is expected to be published in the week beginning 2 February 2026.
Previous findings focused on individual substances and their health consequences.